IBRX earnings: a negative outcome, -17.1%

On November 9, 2023, ImmunityBio, Inc. reached its earnings. The result was a negative outcome, and the stock moved -17.1% in the window around the event. It had already run +151.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.